July 9, 2014
Lynda Dee of the Fair Pricing Coalition (FPC) spoke with coworkers Jeff Berry and Murray Penner, as well as David Evans of Project Inform, about access to HIV and hepatitis C (HCV) medications. FPC negotiates with pharmaceutical companies to make these drugs affordable for patients. Ongoing programs include a co-pay card that will cover medication co-payments and a patient assistance program for people without health insurance. In response to the Affordable Care Act (ACA), a third program is intended to cover coinsurance payments or deductibles for the ACA-sponsored Bronze plans. However, government agencies still disagree about whether such coverage will be permitted. Also mentioned was the fact that some HIV and HCV medications are not on insurance companies' lists of drugs they cover (so-called formularies). The panelists asked viewers to advocate with their local members of Congress around some of these issues.
Watch the video to learn more:
About the panelists:
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.
Barbara Jungwirth is a freelance writer and translator based in New York.
Follow Barbara on Twitter: @reliabletran.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Long-Acting HIV Treatment: 5 Myths and Realities|
|IL-1β Inhibitor Lowers Arterial Inflammation in Adults With Controlled HIV|
|Two-Drug HIV Treatment Regimens Effective in Latest Studies|
|The Need to Advocate for Fair HIV Drug Prices|
|'Stop Describing, Start Intervening': Can the CDC's New Viral Load Data Help Guide HIV Programs?|
|Weekly Injections of Antibody PRO 140 Keep HIV Undetectable in 10 of 16 Patients|